🔎 Trials Near Me

Home › Breast Cancer › New Mexico › Rio Rancho

Breast Cancer clinical trials in Rio Rancho, NM

6 studies for Breast Cancer are looking for participants at sites in and around Rio Rancho (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

RecruitingObservational studyHealthy volunteers welcome
  • Presbyterian Rust Medical Center/Jorgensen Cancer Center, Rio Rancho
Ages 40 to 75 · All sexes · Updated Oct 2, 2026 · NCT05334069

A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)

RecruitingPhase 3
  • Presbyterian Rust Jorgensen Cancer ( Site 0073), Rio Rancho
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT07060807

The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study

RecruitingPhase 3
  • Presbyterian Rust Medical Center/Jorgensen Cancer Center, Rio Rancho
Ages 60 and older · All sexes · Updated Sep 25, 2026 · NCT06377852

Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation

RecruitingPhase 3
  • Presbyterian Rust Cancer Center, Rio Rancho
Ages 18 and older · All sexes · Updated Jun 22, 2026 · NCT05696626

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

RecruitingObservational study
  • Presbyterian Rust Medical Center/Jorgensen Cancer Center, Rio Rancho
Ages 18 and older · All sexes · Updated Mar 17, 2026 · NCT06418204

About Breast Cancer

Breast cancer is a cancer that starts in the breast tissue, when cells change and grow out of control. These extra cells can form a mass called a tumor.

More about Breast Cancer on MedlinePlus

Breast Cancer trials in other cities

Other studies in Rio Rancho

From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.